ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2

(2022) Lamiaa El-Shennawy et al.   Nature Communications

Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19

(2022) Artemio García-Escobar et al.   Biomolecules

Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS‐CoV‐2 spike protein

(2021) Lydia Horndler et al.   EMBO Molecular Medicine

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

(2021) Man Lung Yeung et al.   CELL

Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers

(2021) Javier Martínez-Sanz et al.   Emerging Microbes & Infections

Plasma ACE2 species are differentially altered in COVID‐19 patients

(2021) María‐Salud García‐Ayllón et al.   FASEB JOURNAL

Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS

(2021) Ugo Bastolla   Frontiers in Molecular Biosciences

Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In Nicotiana benthamiana Plant With Potent Anti-SARS-CoV-2 Activity

(2021) Tarlan Mamedov et al.   Frontiers in Plant Science

Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review

(2021) Bhagat Singh et al.   Journal of Pharmaceutical Analysis

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics

(2020) David Gurwitz   DRUG DEVELOPMENT RESEARCH

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

(2020) Bo Shen et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

(2020) Daniel Batlle et al.   CLINICAL SCIENCE

COVID‐19: focus on the lungs but do not forget the gastrointestinal tract

(2020) Wiktor Smyk et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

(2020) Paolo Verdecchia et al.   European Journal of Internal Medicine

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

(2020) James Brett Case et al.   Cell Host & Microbe

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

(2020) Kasper Iversen et al.   LANCET INFECTIOUS DISEASES

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

(2020) Alberto L. Garcia-Basteiro et al.   Nature Communications

Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?

(2020) Gregor Majdic   Frontiers in Cellular and Infection Microbiology

Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study

(2020) Kang Zhao et al.   Open Forum Infectious Diseases

Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19

(2020) Marina Rieder et al.   AMERICAN JOURNAL OF HYPERTENSION

Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff

(2020) C. Martin et al.   JOURNAL OF HOSPITAL INFECTION

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

(2020) Sukrit Narula et al.   LANCET

Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

(2020) Jude Moutchia et al.   PLoS One

ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle

(2020) Zaid Abassi et al.   Frontiers in Physiology

Human recombinant soluble ACE2 in severe COVID-19

(2020) Alexander Zoufaly et al.   Lancet Respiratory Medicine

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

(2020) Donato Zipeto et al.   Frontiers in Immunology

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020

(2020) Wesley H. Self et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India

(2020) Anshika Srivastava et al.   Frontiers in Genetics

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

(2020) Carlo Cervia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19

(2020) Sarita Choudhary et al.   Annals of Laboratory Medicine

Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia

(2009) Hong Peng Jia et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY